Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pill offers hope for patients with Tough-to-Treat lymphoma

NCT ID NCT03930953

Ongoing Disease control Sponsor: Celgene Source: ClinicalTrials.gov ↗

Summary

This study is testing a new oral drug called CC-99282 for people with non-Hodgkin lymphoma that has come back or hasn't responded to previous treatments. Researchers want to find the safest and most effective dose, both when given alone and when combined with other lymphoma drugs. The main goals are to check for side effects and see if the drug helps control the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOMA, NON-HODGKIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Local Institution - 101

    Houston, Texas, 77030, United States

  • Local Institution - 102

    Tampa, Florida, 32207, United States

  • Local Institution - 103

    Hackensack, New Jersey, 07601, United States

  • Local Institution - 104

    St Louis, Missouri, 63110, United States

  • Local Institution - 107

    Rochester, Minnesota, 55905, United States

  • Local Institution - 108

    Overland Park, Kansas, 66210, United States

  • Local Institution - 109

    Scottsdale, Arizona, 85259, United States

  • Local Institution - 111

    Jacksonville, Florida, 32224, United States

  • Local Institution - 150

    Jerusalem, 91120, Israel

  • Local Institution - 151

    Petah Tikva, 49100, Israel

  • Local Institution - 152

    Ramat Gan, 52621, Israel

  • Local Institution - 201

    Toronto, Ontario, M5G 2M9, Canada

  • Local Institution - 253

    Buenos Aires, C1431FWO, Argentina

  • Local Institution - 254

    Pilar, Buenos Aires, 1629, Argentina

  • Local Institution - 255

    Ciudad Autonoma de Buenos Aires, Buenos Aires, C1118AAT, Argentina

  • Local Institution - 301

    Barcelona, 08035, Spain

  • Local Institution - 302

    Madrid, 28040, Spain

  • Local Institution - 303

    Málaga, 29010, Spain

  • Local Institution - 304

    Madrid, 28046, Spain

  • Local Institution - 305

    Salamanca, 37007, Spain

  • Local Institution - 306

    Badalona (Barcelona), 08916, Spain

  • Local Institution - 350

    Santiago, RM, 7560908, Chile

  • Local Institution - 352

    Santiago, Santiago Metropolitan, 8320000, Chile

  • Local Institution - 353

    Santiago, Santiago Metropolitan, 7500921, Chile

  • Local Institution - 354

    Santiago, Metropolitana de Santiago, 7580206, Chile

  • Local Institution - 355

    Recoleta, Santiago Metropolitan, 842 0383, Chile

  • Local Institution - 401

    Villejuif, 94805, France

  • Local Institution - 402

    Pierre-Bénite, 69495, France

  • Local Institution - 403

    Créteil, 94010, France

  • Local Institution - 404

    Rouen, 76038, France

  • Local Institution - 405

    Paris, 75010, France

  • Local Institution - 406

    Lille, 59037, France

  • Local Institution - 407

    Bordeaux, 33076, France

  • Local Institution - 408

    Toulouse, 31200, France

  • Local Institution - 409

    Montpellier, 34295, France

  • Local Institution - 450

    São Paulo, São Paulo, 05651-901, Brazil

  • Local Institution - 451

    São Paulo, 01401-002, Brazil

  • Local Institution - 452

    São Paulo, 1246000, Brazil

  • Local Institution - 453

    Porto Alegre, Rio Grande do Sul, 90610-000, Brazil

  • Local Institution - 501

    Bergamo, 24127, Italy

  • Local Institution - 502

    Naples, 80131, Italy

  • Local Institution - 503

    Milan, 20162, Italy

  • Local Institution - 504

    Bologna, 40138, Italy

  • Local Institution - 506

    Pavia, 27100, Italy

  • Local Institution - 550

    Seoul, 06351, South Korea

  • Local Institution - 551

    Seoul, 03080, South Korea

  • Local Institution - 552

    Seoul, 06591, South Korea

  • Local Institution - 553

    Busan, 47392, South Korea

  • Local Institution - 601

    Copenhagen, 2100, Denmark

  • Local Institution - 602

    Aarhus, 8200, Denmark

  • Local Institution - 603

    Vejle, 7100, Denmark

  • Local Institution - 650

    Shanghai, Shanghai Municipality, 200025, China

  • Local Institution - 651

    Tianjin, Tianjin Municipality, 300060, China

  • Local Institution - 653

    Beijing, Beijing Municipality, 100020, China

  • Local Institution - 655

    Zhengzhou, Henan, 450000, China

  • Local Institution - 657

    Guangzhou, Guangdong, 510080, China

  • Local Institution - 659

    Guangzhou, 510060, China

  • Local Institution - 660

    Wuhan, Hubei, 430079, China

  • Local Institution - 662

    Shenyang, Liaoning, 110001, China

  • Local Institution - 663

    Shenyang, Liaoning, 110022, China

  • Local Institution - 701

    Salzburg, 5020, Austria

  • Local Institution - 703

    Vienna, 1090, Austria

  • Local Institution - 704

    Sankt Pölten, 3100, Austria

  • Local Institution - 802

    Edinburgh Scotland, EH4 2XU, United Kingdom

  • Local Institution - 803

    Southhampton, SO01 6YD, United Kingdom

  • Local Institution - 902

    Leuven, 3000, Belgium

Conditions

Explore the condition pages connected to this study.

LYMPHOMA, NON-HODGKIN